Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled Type 2 diabetic patients

被引:118
作者
Targher, G
Bertolini, L
Padovani, R
Poli, F
Scala, L
Zenari, L
Zoppini, G
Falezza, G
机构
[1] Osped Sacro Cuore G Calabria, Serv Diabetol, Dept Internal Med, I-37024 Negrar, VR, Italy
[2] Sacro Cuore Hosp, Dept Radiol, Negrar, VR, Italy
[3] Univ Verona, Div Endocrinol & Metab Dis, I-37100 Verona, Italy
关键词
non-alcoholic fatty liver; atherosclerosis; cardiovascular risk factors; metabolic syndrome; insulin resistance; Type; 2; diabetes;
D O I
10.1007/BF03349177
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Non-alcoholic fatty liver disease (NAFLD) is closely associated with several metabolic syndrome (MetS) features. We assessed whether NAFLD is significantly associated with carotid artery intima-media thickness (IMT), as a marker of subclinical atherosclerosis, and whether such association is independent of classical cardiovascular risk factors and MetS features. We studied 100 diet-controlled Type 2 diabetic patients with ultrasonographically diagnosed NAFLD and 100 diabetic patients without NAFLD who were comparable for age and sex. Main outcome measures were carotid IMT (by ultrasonography), classical risk factors, insulin resistance [as estimated by homeostasis model assessment (HOMA)-IR] and MetS (as defined by the Adult Treatment Panel III criteria). NAFLD patients had a markedly greater carotid IMT (1.24 +/- 0.13 vs 0.95 +/- 0.11 mm; p<0.001) than those without the condition. The MetS and all its clinical traits were more highly prevalent in those with NAFLD (p<0.001). Adjustment for age, sex, smoking history, diabetes duration, glycosylated hemoglobin, LDL cholesterol, liver enzymes and microalbuminuria did not really affect the significant differences in carotid IMT that were observed between the groups. Further adjustment for the MetS also had little impact, but additional adjustment for HOMA-IR score consistently attenuated any statistical significance (p=0.28). In multivariate regression analysis, HOMA-IR score along with age and MetS (principally raised blood pressure values) were independently related to carotid IMT, whereas NAFLD was not. In conclusion, these results suggest that among diet-controlled Type 2 diabetic individuals the significant increase of carotid IMT in the presence of NAFLD is largely explained by HOMA-estimated insulin resistance.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 23 条
[1]
Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[2]
Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients - Relationship with insulin resistance [J].
Bonora, E ;
Tessari, R ;
Micciolo, R ;
Zenere, M ;
Targher, G ;
Padovani, R ;
Falezza, G ;
Muggeo, M .
DIABETES CARE, 1997, 20 (04) :627-631
[3]
The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study [J].
Bonora, E ;
Targher, G ;
Formentini, G ;
Calcaterra, F ;
Lombardi, S ;
Marini, F ;
Zenari, L ;
Saggiani, F ;
Poli, M ;
Perbellini, S ;
Raffaelli, A ;
Gemma, L ;
Santi, L ;
Bonadonna, RC ;
Muggeo, M .
DIABETIC MEDICINE, 2004, 21 (01) :52-58
[4]
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity [J].
Bonora, E ;
Saggiani, F ;
Targher, G ;
Zenere, MB ;
Alberiche, M ;
Monauni, T ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2000, 23 (01) :57-63
[5]
Nonalcoholic fatty liver disease is associated with carotid atherosclerosis -: A case-control study [J].
Brea, A ;
Mosquera, D ;
Martín, E ;
Arizti, A ;
Cordero, JL ;
Ros, E .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (05) :1045-1050
[6]
Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis [J].
Chalasani, N ;
Deeg, MA ;
Crabb, DW .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (08) :1497-1502
[7]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]
Beyond insulin resistance in NASH:: TNF-α or adiponectin? [J].
Hui, JM ;
Hodge, A ;
Farrell, GC ;
Kench, JG ;
Kriketos, A ;
George, J .
HEPATOLOGY, 2004, 40 (01) :46-54
[9]
Cardiovascular morbidity and mortality associated with the metabolic syndrome [J].
Isomaa, B ;
Almgren, P ;
Tuomi, T ;
Forsén, B ;
Lahti, K ;
Nissén, M ;
Taskinen, MR ;
Groop, L .
DIABETES CARE, 2001, 24 (04) :683-689
[10]
COMPARISON OF LIVER HISTOLOGY WITH ULTRASONOGRAPHY IN ASSESSING DIFFUSE PARENCHYMAL LIVER-DISEASE [J].
JOSEPH, AEA ;
SAVERYMUTTU, SH ;
ALSAM, S ;
COOK, MG ;
MAXWELL, JD .
CLINICAL RADIOLOGY, 1991, 43 (01) :26-31